Phlebologie 2014; 43(01): 37-41
DOI: 10.12687/phleb2161-1-2014
Mexican Sclerotherapy Consensus
Schattauer GmbH

1. Mexikanische Sklerotherapie Leitlinie

Article in several languages: deutsch | English
F. Vega
1   Mexican Academy of Phlebology and Lymphology
,
C. Ramírez
1   Mexican Academy of Phlebology and Lymphology
,
C. Lemoine
1   Mexican Academy of Phlebology and Lymphology
,
H. Cázares
1   Mexican Academy of Phlebology and Lymphology
,
A. Ramírez
1   Mexican Academy of Phlebology and Lymphology
,
E. Jiménez
1   Mexican Academy of Phlebology and Lymphology
,
F. Rendón
1   Mexican Academy of Phlebology and Lymphology
,
R. Castañeda
1   Mexican Academy of Phlebology and Lymphology
,
L. Arias
1   Mexican Academy of Phlebology and Lymphology
› Author Affiliations
Further Information

Publication History

Received: 01 August 2013

Accepted: 05 August 2013

Publication Date:
04 January 2018 (online)

Summary

Background: Sclerotherapy has been carried out since 1516 and is accepted and performed wordwide according to many references from books and journals. Mexican doctors have participated in other consensuses in order to obtain various agreements, references, methods and procedures that are universally accepted for establishing this document, including the European Consensus of Sclerotherapy 2003 and its last revision in 2006, the Argentine and Latin American Consensus 2012 and various sources from the literature.

Objective: Based on the worldwide literature and the experience of specialists in phlebosclerosis, the objective is to develop a document that combines concepts, preferences, differences and variations on the basis of diagnosis, use, treatment and other related subjects involving sclerotherapy so that this document will be of value as a reference from an academic, medical, legal and practical standpoint.

Method: General questions about sclerotherapy were established concerning: indications, contraindications, types of sclerosant and the concentrations used, positioning, of the patient, methods of application, method of preparing and preserving sclerosants necessary equipment, injection volumes, administration variables, compression, and special comments.

To answer these questions the existing literature and the topics in which the reports showed uniformity were consulted. A panel of experts was constituted who provided reports of their personal experience, on the basis of which answers were formulated in the form of clinical guidelines or recommendations expressed in a general way, including observations on the variability of the concepts embodied, in order to provide concrete answers to the specific questions and a section of observations where possible accepted variations on each particular issue are explained. The main text expresses the 100% consensus on the issue, and thetext accompanied by the blue bar lists the variations given by the experts. As the listed points are discussed on the basis of substances that can be purchased in Mexico, some sclerosing agents or equipment are not covered.

This article is available in Spanish at www.phlebologieonline.de